Literature DB >> 18305031

Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease.

Jiahai Shi1, J Sivaraman, Jianxing Song.   

Abstract

Unlike 3C protease, the severe acute respiratory syndrome coronavirus (SARS-CoV) 3C-like protease (3CLpro) is only enzymatically active as a homodimer and its catalysis is under extensive regulation by the unique extra domain. Despite intense studies, two puzzles still remain: (i) how the dimer-monomer switch is controlled and (ii) why dimerization is absolutely required for catalysis. Here we report the monomeric crystal structure of the SARS-CoV 3CLpro mutant R298A at a resolution of 1.75 A. Detailed analysis reveals that Arg298 serves as a key component for maintaining dimerization, and consequently, its mutation will trigger a cooperative switch from a dimer to a monomer. The monomeric enzyme is irreversibly inactivated because its catalytic machinery is frozen in the collapsed state, characteristic of the formation of a short 3(10)-helix from an active-site loop. Remarkably, dimerization appears to be coupled to catalysis in 3CLpro through the use of overlapped residues for two networks, one for dimerization and another for the catalysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305031      PMCID: PMC2293028          DOI: 10.1128/JVI.02680-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50.

Authors:  Steven Hayward; Richard A Lee
Journal:  J Mol Graph Model       Date:  2002-12       Impact factor: 2.518

2.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

3.  SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.

Authors:  Vito Graziano; William J McGrath; Lin Yang; Walter F Mangel
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

4.  Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride.

Authors:  Hui-Ping Chang; Chi-Yuan Chou; Gu-Gang Chang
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

5.  Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases.

Authors:  M Allaire; M M Chernaia; B A Malcolm; M N James
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

6.  Long-range cooperative interactions modulate dimerization in SARS 3CLpro.

Authors:  Jennifer Barrila; Usman Bacha; Ernesto Freire
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

7.  Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.

Authors:  Wen-Chi Hsu; Hui-Chuan Chang; Chi-Yuan Chou; Pui-Jen Tsai; Pei-In Lin; Gu-Gang Chang
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

8.  Mechanism of the maturation process of SARS-CoV 3CL protease.

Authors:  Min-Feng Hsu; Chih-Jung Kuo; Kai-Ti Chang; Hui-Chuan Chang; Chia-Cheng Chou; Tzu-Ping Ko; Hui-Lin Shr; Gu-Gang Chang; Andrew H-J Wang; Po-Huang Liang
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

9.  The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.

Authors:  Jiahai Shi; Jianxing Song
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

10.  Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.

Authors:  Chih-Jung Kuo; Ya-Hui Chi; John T-A Hsu; Po-Huang Liang
Journal:  Biochem Biophys Res Commun       Date:  2004-06-11       Impact factor: 3.575

View more
  55 in total

1.  Temperature-sensitive mutants and revertants in the coronavirus nonstructural protein 5 protease (3CLpro) define residues involved in long-distance communication and regulation of protease activity.

Authors:  Christopher C Stobart; Alice S Lee; Xiaotao Lu; Mark R Denison
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity.

Authors:  Christopher C Stobart; Nicole R Sexton; Havisha Munjal; Xiaotao Lu; Katrina L Molland; Sakshi Tomar; Andrew D Mesecar; Mark R Denison
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.

Authors:  Haina Qin; Jiahai Shi; Roberta Noberini; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

4.  SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.

Authors:  Tomonari Muramatsu; Chie Takemoto; Yong-Tae Kim; Hongfei Wang; Wataru Nishii; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

5.  Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .

Authors:  Jennifer Barrila; Sandra B Gabelli; Usman Bacha; L Mario Amzel; Ernesto Freire
Journal:  Biochemistry       Date:  2010-05-25       Impact factor: 3.162

6.  Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease.

Authors:  Shu-Chun Cheng; Gu-Gang Chang; Chi-Yuan Chou
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

7.  X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.

Authors:  Sebastian Günther; Patrick Y A Reinke; Yaiza Fernández-García; Julia Lieske; Thomas J Lane; Helen M Ginn; Faisal H M Koua; Christiane Ehrt; Wiebke Ewert; Dominik Oberthuer; Oleksandr Yefanov; Susanne Meier; Kristina Lorenzen; Boris Krichel; Janine-Denise Kopicki; Luca Gelisio; Wolfgang Brehm; Ilona Dunkel; Brandon Seychell; Henry Gieseler; Brenna Norton-Baker; Beatriz Escudero-Pérez; Martin Domaracky; Sofiane Saouane; Alexandra Tolstikova; Thomas A White; Anna Hänle; Michael Groessler; Holger Fleckenstein; Fabian Trost; Marina Galchenkova; Yaroslav Gevorkov; Chufeng Li; Salah Awel; Ariana Peck; Miriam Barthelmess; Frank Schlünzen; P Lourdu Xavier; Nadine Werner; Hina Andaleeb; Najeeb Ullah; Sven Falke; Vasundara Srinivasan; Bruno Alves França; Martin Schwinzer; Hévila Brognaro; Cromarte Rogers; Diogo Melo; Joanna J Zaitseva-Doyle; Juraj Knoska; Gisel E Peña-Murillo; Aida Rahmani Mashhour; Vincent Hennicke; Pontus Fischer; Johanna Hakanpää; Jan Meyer; Philip Gribbon; Bernhard Ellinger; Maria Kuzikov; Markus Wolf; Andrea R Beccari; Gleb Bourenkov; David von Stetten; Guillaume Pompidor; Isabel Bento; Saravanan Panneerselvam; Ivars Karpics; Thomas R Schneider; Maria Marta Garcia-Alai; Stephan Niebling; Christian Günther; Christina Schmidt; Robin Schubert; Huijong Han; Juliane Boger; Diana C F Monteiro; Linlin Zhang; Xinyuanyuan Sun; Jonathan Pletzer-Zelgert; Jan Wollenhaupt; Christian G Feiler; Manfred S Weiss; Eike-Christian Schulz; Pedram Mehrabi; Katarina Karničar; Aleksandra Usenik; Jure Loboda; Henning Tidow; Ashwin Chari; Rolf Hilgenfeld; Charlotte Uetrecht; Russell Cox; Andrea Zaliani; Tobias Beck; Matthias Rarey; Stephan Günther; Dusan Turk; Winfried Hinrichs; Henry N Chapman; Arwen R Pearson; Christian Betzel; Alke Meents
Journal:  Science       Date:  2021-04-02       Impact factor: 47.728

8.  In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.

Authors:  Inemesit A Udofia; Kofoworola O Gbayo; Oluwakemi A Oloba-Whenu; Taofeek B Ogunbayo; Chukwuemeka Isanbor
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-03-25

9.  Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants.

Authors:  Marko Jukič; Blaž Škrlj; Gašper Tomšič; Sebastian Pleško; Črtomir Podlipnik; Urban Bren
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

10.  An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease.

Authors:  Tianhua Zhai; Fangyuan Zhang; Shozeb Haider; Daniel Kraut; Zuyi Huang
Journal:  Front Mol Biosci       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.